Healthcare (blood bank)
Healthcare on the Rise
What is the solution for a business with shrinking margins in a consolidating sector?
Read the full case
sectors
Financial advisory for healthcare companies
JK Capital advises on M&A, capital raising and debt in Healthcare, with 42 public transactions listed on this site. Mandates are led directly by partners with sector experience.
JK Capital advises healthcare companies on sell-side and buy-side transactions, capital raising and debt structuring. Its published track record spans hospitals, clinics, diagnostic medicine, blood banking, dental care, ophthalmology and support services in a sector shaped by consolidation, regulation and long-term capital decisions.
Market read
The hospital consolidation cycle has lost intensity compared with the most active years. Today, a transaction tends to move forward when the asset has clear strategic relevance for the buyer, whether through location, medical specialty, installed capacity, reputation or complementarity with an existing network.
In clinics, diagnostic medicine, ophthalmology, dentistry and other healthcare services, opportunities remain, but buyers are more selective. Beyond growth, they assess cash generation, dependence on founding physicians, concentration of health-plan contracts, quality of care and integration potential.
JK Capital advises healthcare companies on sale preparation, valuation, investor outreach, acquisitions and capital structuring. Our work starts from the characteristics of the asset and the real map of buyers, without assuming that every consolidation move will result in a transaction.
How we help
M&A Sell-Side
Comprehensive sell-side advisory, from valuation to the closing of the definitive agreement.
M&A Buy-Side
Planning and execution of consolidation strategies for strategic buyers and private equity funds.
Fundraising
Raising capital from strategic investors, private equity funds, and development finance institutions.
DCM: Debt Structuring
Access to capital markets through debentures, commercial paper, CRIs, CRAs, and FIDCs.
Related public transactions
See all transactions- Sell-Side
Grupo Fleury (FLRY3) acquired Unilab, a clinical laboratory network in Atibaia and the surrounding region.
JK Capital acted as financial advisor to Unilab.
- Debt Capital Markets
Issuance of a Commercial Note by Grupo Cartão de Todos, in the amount of R$82.5 million.
JK Capital acted as exclusive financial advisor to Grupo Cartão de Todos.
- Sell-Side
Grupo Fleury (FLRY3) acquired 100% of Confiance.
JK Capital acted as exclusive financial advisor to Confiance.
- Sell-Side
Vision One acquired 100% of Centro de Oftalmologia Avançada (COA).
JK Capital acted as exclusive financial advisor to COA.
- Sell-Side
Vision One acquired Hospital de Olhos de Florianópolis (HOF).
JK Capital acted as exclusive financial advisor to HOF.
- Sell-Side
Care Plus completed the acquisition of Inpao Dental.
JK Capital acted as exclusive financial advisor to Inpao Dental.
This selection shows public transactions only and does not represent the entirety of JK Capital's mandates.
Featured case
Team experience
JK in the media
See JK in the mediaBloomberg Línea · 01/10/2026
Fleury acquires Unilab laboratory for R$ 55 million and expands in inland São Paulo and Minas Gerais
Original article in Portuguese
Open articleValor Econômico · 01/10/2026
Fleury buys Unilab laboratory for R$ 55 million
Original article in Portuguese
Open articleUOL/Estadão · 12/16/2020
Onda de fusões e aquisições promete reforçar consolidação do setor de saúde
Original article in Portuguese
Open article
Every market read is made case by case. Talk to a partner about your business context.
Updated on